hit counter

Statins and Dementia Risk: No Long-Term Signal in 322,358 Patients

Statins do not look like a dementia-prevention drug, but they do not look like a dementia hazard either. In 322,358 Kaiser Permanente Northern California patients followed for an average of 11.8 years, dementia diagnoses rose right after statins were started, then flattened: after the first year, the hazard ratio for Alzheimer’s disease and related dementias …

Read more

Social Cognition After Stroke/TBI: Insula-Cingulate Hub

Editorial card showing a stylized brain with the insula, cingulate, middle frontal gyrus, and corpus callosum highlighted, representing the convergent neural substrates of social cognition after acquired brain injury.

A 2026 PRISMA systematic review by Cavallo et al. in Cognitive, Affective, & Behavioral Neuroscience aggregates 43 neuroimaging studies of social cognition in adults with stroke or traumatic brain injury and finds the same handful of regions implicated again and again: the insula, cingulate cortex, middle frontal gyrus, and corpus callosum.1 Research Highlights Stroke/TBI social-cognition …

Read more

Right OFC rTMS Improves Memory in Early Schizophrenia

Editorial card showing a coronal brain section highlighting the right orbitofrontal cortex with a TMS coil, illustrating the first RCT of OFC stimulation in first-episode schizophrenia.

Cognitive impairment in first-episode schizophrenia (FES) is the symptom that does the most work blocking employment, relationships, and independent living — and the symptom current antipsychotics barely move. A 2026 RCT by Hu et al. in Psychological Medicine tested whether 20 sessions of low-frequency rTMS targeting the right orbitofrontal cortex (OFC) could improve cognition where …

Read more

Twin Study Finds No Broad Cytokine Link to Depression or Alcohol Use Disorder

Photoreal illustration of cytokine molecules and brain imagery, conveying inflammation-depression hypothesis under scrutiny.

The broad cytokine story failed its most direct community test: in 972 adults, depression, alcohol use, and alcohol use disorder (AUD) were not associated with C-reactive protein (CRP) or a pre-registered pro-inflammatory cytokine index. The only multiple-testing-corrected cytokine hits ran opposite the hypothesis — AUD was linked to lower IL-1β, IL-4, IL-10, and IL-12 — …

Read more

TRD MRI Coupling Classified Depression Resistance Above 0.88 AUC

A 2026 multimodal MRI study found that treatment-resistant depression had lower coordination between brain structure and brain activity than non-treatment-resistant depression in frontal, parietal, motor, and temporal regions. Machine-learning models using those structure-function coupling measures classified treatment-resistant vs. non-treatment-resistant depression with AUC values from 0.886 to 0.950 in the primary atlas analysis.1 Research Highlights TRD …

Read more

Naltrexone Reduced Reappraisal Distress in 38-Person Threat fMRI Trial

Photoreal illustration of brain with vmPFC, amygdala, and threat-processing circuitry highlighted under pharmacological challenge.

The endogenous opioid system has been a candidate target for novel anxiety treatments, but a 2026 placebo-controlled crossover fMRI study in 38 healthy volunteers ran opposite the hypothesis: instead of increasing threat-related distress and amygdala reactivity, 50 mg oral naltrexone reduced subjective distress during cognitive reappraisal (p = 0.044, d = 0.57) and shifted ventromedial …

Read more

Subcallosal Cingulate DBS for Treatment-Resistant Depression

MHD featured image for Subcallosal Cingulate DBS for Treatment-Resistant Depression.

A 2026 systematic review of subcallosal cingulate (SCC) functional connectivity found 28 qualifying resting-state fMRI studies in depression: 21 rTMS/iTBS studies, 4 ECT studies, 3 focused-ultrasound studies, and 0 DBS or tDCS studies.1 That number is the useful correction: SCC DBS may still be biologically plausible, but the current fMRI connectivity literature mostly explains noninvasive …

Read more